Fierce Pharma
DECEMBER 11, 2023
After many years of tracking the pharmaceutical industry’s pricing tactics, the Institute for Clinical and Economic Review (ICER) is once again placing a spotlight on the price increases that end u | The Institute for Clinical and Economic Review (ICER)’s fifth annual report on unsupported price increases (UPI) puts Humira in the top spot of offenders.
MedCity News
DECEMBER 11, 2023
Fruit Street Health’s complaint alleged that Sharecare violated the terms of their shared business agreement by rolling out its own version of Fruit Street’s diabetes prevention program, which had been previously offered to Sharecare members. Sharecare said that the lawsuit is baseless.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 11, 2023
ASH: Abecma’s survival data show why FDA wanted expert meeting on the Bristol Myers cell therapy aliu Mon, 12/11/2023 - 14:51
European Pharmaceutical Review
DECEMBER 11, 2023
Results from MaaT Pharma’s Early Access Program (EAP) for its microbiome-based therapy MaaT013, have demonstrated positive overall response and overall survival rates in European patients with graft-versus-host disease (GvHD). The findings were presented at the 2023 American Society of Hematology (ASH) Annual Meeting. MaaT013 is an off-the-shelf, pooled-donor, enema Microbiome Ecosystem Therapy TM.
Fierce Pharma
DECEMBER 11, 2023
Sanofi has been in the Egyptian manufacturing game for decades, but that doesn’t mean the French pharma can’t use a helping hand from time to time. | Under a new exclusive deal with Sanofi, local drugmaker Minapharm has been put in control over manufacturing and supply of the popular anticoagulant Clexane in Egypt.
Pharmaceutical Technology
DECEMBER 11, 2023
Trends in sustainability and quality assurance were key themes discussed at the recent CPHI Europe 2023 meeting, although the data reveals a lack of implementation of sustainable solutions.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmExec
DECEMBER 11, 2023
Phase III trial to investigate novel individualized neoantigen therapy V940 (mRNA-4157) in combination with Keytruda (pembrolizumab) as an adjuvant treatment for patients with completely resected Stage II, IIIA, or IIIB non-small cell lung cancer.
Fierce Pharma
DECEMBER 11, 2023
Earlier this year, Fierce Healthcare, Fierce Pharma and Fierce Biotech recognized 50 individuals and companies that are pushing the industry forward. | The Fierce 50 honorees range from tech innovators to researchers developing novel therapies to providers on the frontlines of changing care. This week on "The Top Line," senior editor Paige Minemyer sat down with staff writers Dave Muoio and Anastassia Gliadkovskaya as well as senior editor Heather Landi to discuss a few of the honorees
MedCity News
DECEMBER 11, 2023
In a letter to CMS, four senators asked for better data collection on the practices of Medicare Advantage plans, including when it comes to prior authorization.
Copyright Clearance Center
DECEMBER 11, 2023
December 11, 2023 – Danvers, Mass. – CCC , a pioneer in voluntary collective licensing, advancing copyright, accelerating knowledge, and powering innovation, has been named one of the Top Places to Work in Massachusetts in the large employer category for the third year in a row in the 15 th annual employee-based survey project from The Boston Globe.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
DECEMBER 11, 2023
Privia Medical Group Gulf Coast has launched Privia Wellness, which offers weight management, hormone replacement therapy, sleep and brain health and nutraceuticals. The weight management support is provided by Iron Health, a virtual care platform.
Integrity Solutions
DECEMBER 11, 2023
What is cold calling and what does it look like in the current sales world? Your mindset may actually be the key to success. If you want to hear salespeople groan, mention cold calling. It’s true that cold calling can be hard, grinding-it-out work, and the rewards aren’t instant. But sales prospecting is the bread-and-butter, core activity that leads to sales growth and success — and cold calling is one of the most effective prospecting strategies available.
MedCity News
DECEMBER 11, 2023
TEFCA’s goal is to establish a universal floor for interoperability across the country by developing the infrastructure model and governing approach for users in different networks to securely share basic clinical information with each other.
European Pharmaceutical Review
DECEMBER 11, 2023
The European Commission (EC) has approved the first frontline immuno-oncology treatment in the EU for mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer. GSK’s Jemperli (dostarlimab) plus carboplatin-paclitaxel chemotherapy is indicated for these patients who are suitable for systemic therapy.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
DECEMBER 11, 2023
The future of clinical research is a connected user experience with automated workflows, streamlined document exchange and transparency to accelerate studies without compromising compliance.
Medgadget
DECEMBER 11, 2023
Researchers at the University of Waterloo in Canada have developed plant-based microrobots that are intended to pave the way for medical robots that can enter the body and perform tasks, such as obtaining a biopsy or performing a surgical procedure. The robots consist of a hydrogel material that is biocompatible and the composite contains cellulose nanoparticles derived from plants.
MedCity News
DECEMBER 11, 2023
Novartis drug iptacopan, which won its first FDA approval in early December in a rare blood disorder, has met the main goal of a pivotal test in an ultra-rare kidney disease. The small molecule’s potential to address many diseases has stirred up blockbuster expectations.
PharmaTimes
DECEMBER 11, 2023
New data highlights the inequalities in emergency hospital rates and vaccinations - News - PharmaTimes
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
DECEMBER 11, 2023
The FDA has approved Vertex/CRISPR’s Casgevy and bluebird bio’s Lyfgenia gene therapies for the red blood cell disorder.
PharmaTimes
DECEMBER 11, 2023
Around 2,100 GP surgeries had enrolled into the digital service by the end of November - News - PharmaTimes
Pharmaceutical Commerce
DECEMBER 11, 2023
Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.
Copyright Clearance Center
DECEMBER 11, 2023
Critically for Richard Charkin, the title verso is where to find who is the copyright holder.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Commerce
DECEMBER 11, 2023
Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel.
PharmExec
DECEMBER 11, 2023
Cresemba is now the only azole antifungal treatment approved by the FDA for use in pediatric patients as young as 1 year of age with invasive aspergillosis and invasive mucormycotic.
Pharmaceutical Commerce
DECEMBER 11, 2023
Conference keynote offers an industry outlook, including new commercialization challenges.
PharmExec
DECEMBER 11, 2023
Lack of trust in pharma-provided content proves to be a key barrier to successful engagement, highlighting issues like promotional spin, information availability, and more.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
pharmaphorum
DECEMBER 11, 2023
MSD, Moderna take mRNA jab into phase 3 for lung cancer Phil.
Spotio
DECEMBER 11, 2023
In the dynamic world of field sales, staying connected is crucial. But what happens when you find yourself in a signal dead zone? Enter “Download My Day,” SPOTIO’s game-changing feature designed to keep you in control, even when connectivity is a challenge. Let’s explore how this innovative addition to the SPOTIO app can transform your field experience.
Contrarian Sales Techniques
DECEMBER 11, 2023
As someone who's interested in the furniture market, I've been pondering how you can elevate your store's appeal to budget-conscious consumers. This segment, while price-sensitive, presents a substantial opportunity for growth and loyalty. I'd like to share some targeted strategies that could help you tap into this market more effectively. Of course, you can always take a quick look at my 8 suggestions for increasing furniture sales.
Pharmaceutical Commerce
DECEMBER 11, 2023
To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
228 
Let's personalize your content